8th CAR-TCR Summit

Oncology
8th CAR-TCR Summit

The 8th CAR-TCR Summit is returning to Boston as the industry’s trusted, definitive, end-to-end forum for the global network of autologous and allogeneic cell therapy drug developers. Stay ahead of the curve with unmatched industry insights across a variety of cell types (αβ T, γδ T, NK, NKT, Macrophage, TIL and more).

Across 3 conference days with 8 content tracks, and an additional 6 deep-dive workshops, bootcamp, focus day, diversity session, C-level think tank and more, 200+ CAR and TCR experts will lead you and over 1,000 peers in discussions that will accelerate your pipeline, bringing better drugs to patients faster.

No matter your area of expertise of stage of development, there’s in-depth content for your whole team with dedicated tracks of content for Discovery, Translation, Early Stage Clinical Strategy, Clinical Operations, Manufacturing, CMC & Analytics, Supply Chain & Logistics and Commercialization & Market Access.

View the full 2023 agenda now: https://ter.li/axol9d

Image
CAR-TCR